Rapid tumor regression in an Asian lung cancer patient following personalized neo-epitope peptide vaccination.
about
SLC45A2: A Melanoma Antigen with High Tumor Selectivity and Reduced Potential for Autoimmune Toxicity.A library-based screening method identifies neoantigen-reactive T cells in peripheral blood prior to relapse of ovarian cancer.The Potential of Donor T-Cell Repertoires in Neoantigen-Targeted Cancer Immunotherapy.Trial watch: DNA-based vaccines for oncological indicationsUnique true predicted neoantigens (TPNAs) correlates with anti-tumor immune control in HCC patients
P2860
Rapid tumor regression in an Asian lung cancer patient following personalized neo-epitope peptide vaccination.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Rapid tumor regression in an A ...... o-epitope peptide vaccination.
@en
type
label
Rapid tumor regression in an A ...... o-epitope peptide vaccination.
@en
prefLabel
Rapid tumor regression in an A ...... o-epitope peptide vaccination.
@en
P2093
P2860
P1433
P1476
Rapid tumor regression in an A ...... o-epitope peptide vaccination.
@en
P2093
Caixia Chen
Gregory Lizée
Junqin Gao
Patrick Hwu
Xueming Du
P2860
P304
P356
10.1080/2162402X.2016.1238539
P577
2016-10-07T00:00:00Z